跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AZITHROMYCIN TABLETS 250 MG - HSA Drug Approval Details
Approvals
/
HSA
/
AZITHROMYCIN TABLETS 250 MG
Approved
THERAPEUTIC
AZITHROMYCIN TABLETS 250 MG
Cadila Healthcare Limited
🇸🇬 Health Sciences Authority
Approval Date
Jul 25, 2012
Approval ID
cea58461bccb531a
Company
Cadila Healthcare Limited
Type
Therapeutic
Approval Details
Approval Id
cea58461bccb531a
Drug Name
AZITHROMYCIN TABLETS 250 MG
Product Name
AZITHROMYCIN TABLETS 250 MG
Approval Number
SIN14201P
Approval Date
2012-07-25
Registrant
APOTHECA MARKETING PTE LTD
Licence Holder
APOTHECA MARKETING PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
J01FA10
Atc Item Name
azithromycin
Pharma Manufacturer Name
APOTHECA MARKETING PTE LTD
Company Detail Path
/organization/apotheca-marketing-pte-ltd
Active Ingredients
Azithromycin dihydrate 262.050mg eqv Azithromycin
250mg
AZITHROMYCIN DIHYDRATE 262.05 MG EQV AZITHROMYCIN
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 25, 2012
Approval ID
cea58461bccb531a
Type
Therapeutic
Back to HSA Approvals